MMS Offers $1 Million In-Kind Services For COVID-19 Vaccine Development
CANTON – MMS, a contract biotech research organization, is offering a $1 million award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered as data and related services to qualified pharmaceutical and clinical research companies supporting the commercial development of a vaccine for approval in the





